Dyslexics' Visual Attention Field

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03285789
Collaborator
(none)
1,460
1
3
98.9
14.8

Study Details

Study Description

Brief Summary

dyslexia is often considered like a phonological deficit but some researches show that a visual attention (V-A) deficit can occur in dyslexia. The investigator want to show that some dyslexics have a reduced V-A field in visual search when the investigator use separable feature (letter-like).

If the investigator demonstrate that, he will show that V-A deficit can be transpose to an ability acquired before reading, the visual search. Therefore, the V-A deficit can't be a consequence of reading problem but a cause of it for some dyslexics.

The investigator could imagine an earlier diagnosis for children at risk to develop dyslexia and make reeducation more specific for the deficit observed.

Condition or Disease Intervention/Treatment Phase
  • Other: Passing tests in dyslexics with reduced eva
  • Other: Passing tests in controls
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1460 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Evaluation of the Visuo-attention Field of Symbols Versus Objects Visual Search in Dyslexic Subjects. DyslexiaSPOTLIGHT
Actual Study Start Date :
Jul 25, 2018
Anticipated Primary Completion Date :
Oct 21, 2026
Anticipated Study Completion Date :
Oct 21, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dyslexics with reduced visual attention span

21 subjects diagnosed dyslexics with reduced visual attention span

Other: Passing tests in dyslexics with reduced eva
Visual attention span : the subject see a 5 letters strings during 200 ms and he has to report it orally whatever the order Visual search : the subject has to find a target among distractors (24 or 48) in different conditions of stimuli (conjunction feature or separable feature) and different conditions of view (full view or reduced view with the moving window paradigm) Elementary visuo spatial perception: the subject passes 6 visuo spatial tests to judge his visuo spatial abilities. All of these tests will be made during an unique visit of 1h30.

Experimental: Dyslexics with normal visual attention span

Other: Passing tests in dyslexics with reduced eva
Visual attention span : the subject see a 5 letters strings during 200 ms and he has to report it orally whatever the order Visual search : the subject has to find a target among distractors (24 or 48) in different conditions of stimuli (conjunction feature or separable feature) and different conditions of view (full view or reduced view with the moving window paradigm) Elementary visuo spatial perception: the subject passes 6 visuo spatial tests to judge his visuo spatial abilities. All of these tests will be made during an unique visit of 1h30.

Active Comparator: controls

Other: Passing tests in controls
Visual attention span : the subject see a 5 letters strings during 200 ms and he has to report it verbally whatever the order Visual search : the subject has to find a target among distractors (24 or 48) in different conditions of stimuli (conjunction feature or separable feature) and different conditions of view (full view or reduced view with the moving window paradigm) Elementary visuo spatial perception: the subject passes 6 visuo spatial test to judge his visuo spatial abilities. "test de l'alouette" : reading test during 3 minutes, we note the number of word read and the errors. We obtain lexical age. All of these tests will be made during an unique visit of 1h30.

Outcome Measures

Primary Outcome Measures

  1. Respond time in visual search in different condition of view (full view or reduced view) with separable feature. [Day 0]

    The subject will have to find a target among distractors, when he will find it, he will have to push a button and we will have his respond time. We will compare the respond time in two view condition: the participant will see all the visual scene or he will have reduced visible window so he won't see all the scene, the periphery will be hide and he will have to move his sight to show it.

Secondary Outcome Measures

  1. respond time in function of the distractors' number [Day 0]

    The subject will have to find a target among distractors, when he will find it, he will have to push a button and we will collect his respond time. We compare the respond time between two number of distractors (24 or 48)

  2. visual exploration of the scene [Day 0]

    with an eye tracker the investigator will analyze the ocular movements during visual search (saccades and fixations) and the equip will compare the visual behavior between the different groups and the different conditions.

  3. visuo-spatial perception [Day 0]

    the investigator will test with different exercises the elementary visuo spatial perception of the participant and he will compare between groups and also he will make correlation with the respond time in visual search.

  4. visual attention span (VAS) [Day 0]

    the subject have to report orally a 5 letters' string presented during 200 ms, the investigator could see if a correlation exist between VAS and RT, VAS and visual exploration, VAS and visuo spatial perception.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • normal or corrected to normal vision

  • diagnosed dyslexics with a recent "alouette" test

Exclusion Criteria:
  • other developmental problem (dysphasia, dyspraxia, ADHD)

  • strabismus, amblyopia, oculomotor paralysis

Contacts and Locations

Locations

Site City State Country Postal Code
1 U1028 INSERM - CNRS UMR 5292 Equipe ImpAct Bron France 69500

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

  • Principal Investigator: Laure PISELLA, PhD, INSERM U1028 - Impact - CRNL

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT03285789
Other Study ID Numbers:
  • 69HCL17_0333
  • 2017-A02525-48
First Posted:
Sep 18, 2017
Last Update Posted:
Jul 26, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2022